Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361


Alva A., Csoszi T., ÖZGÜROĞLU M., Matsubara N., Geczi L., Cheng S. Y. , ...More

ESMO Virtual Congress, ELECTR NETWORK, 19 September - 18 October 2020, vol.31 identifier